BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 19008812)

  • 1. [The results of porto-systemic shunting in patients with liver cirrhosis].
    Nazyrov FG; Deviatov AV; Ibadov RA; Khashimov ShKh
    Khirurgiia (Mosk); 2008; (10):32-5. PubMed ID: 19008812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Factors in long-term survival after total portal systemic shunting: a multiple regression analysis].
    Jiang ZM
    Zhonghua Wai Ke Za Zhi; 1989 Nov; 27(11):676-9, 702. PubMed ID: 2632200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preshunt liver function remains the prominent determinant of survival after portasystemic shunting.
    Cowgill SM; Carey E; Villadolid D; Al-Saadi S; Zervos EE; Rosemurgy AS
    Am J Surg; 2006 Nov; 192(5):617-21. PubMed ID: 17071194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Spleno-renal distal and proximal shunts for hypersplenism due to hepatic cirrhosis].
    Bancu S; Borz C; Popescu G; Torok A; Mureşan A; Bancu L; Turcu M
    Chirurgia (Bucur); 2007; 102(6):665-8. PubMed ID: 18323228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small diameter H-graft porta-caval shunt performed at different stages of liver disease.
    Batignani G; Vizzutti F; Rega L; Zuckermann M; Fratini G; Pinzani M; Tonelli F
    Hepatobiliary Pancreat Dis Int; 2004 Nov; 3(4):516-21. PubMed ID: 15567736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Selective portal-systemic shunts for bleeding portal hypertension].
    Orozco H; Mercado MA; Takahashi T; García-Tsao G; Guevara L; Hernandez-Ortiz J; Tielve M
    Rev Invest Clin; 1990 Jul; 42 Suppl():165-9. PubMed ID: 19256158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retrospective evaluation of liver transplantation for cirrhosis: a comparative study of 100 patients with or without previous porto-systemic shunt.
    Turrion VS; Mora NP; Cofer JB; Solomon H; Morris CA; Gonwa TA; Goldstein RM; Husberg BS; Klintmalm GB
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1570-1. PubMed ID: 1989295
    [No Abstract]   [Full Text] [Related]  

  • 8. Cirrhotic patients with a transjugular intrahepatic portosystemic shunt undergoing major extrahepatic surgery.
    Kim JJ; Dasika NL; Yu E; Fontana RJ
    J Clin Gastroenterol; 2009 Jul; 43(6):574-9. PubMed ID: 19169145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postreperfusion syndrome during liver transplantation for cirrhosis: outcome and predictors.
    Paugam-Burtz C; Kavafyan J; Merckx P; Dahmani S; Sommacale D; Ramsay M; Belghiti J; Mantz J
    Liver Transpl; 2009 May; 15(5):522-9. PubMed ID: 19399736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative liver biopsy and survival after portasystemic shunting.
    Lang AP; Patel S; Langer B; Phillips MJ
    Can J Surg; 1981 Sep; 24(5):543-5. PubMed ID: 7284921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Sulfobromophthalein clearance and survival of cirrhotics after an elective porto-systemic shunt].
    Spina GP; Galeotti F; Sorato R; Maffei-Faccioli A; Zotti S; Ghidini O
    Minerva Chir; 1980 Feb; 35(3):135-42. PubMed ID: 7374971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shunt versus transplantation.
    Langnas AN
    Liver Transpl Surg; 1998 Sep; 4(5 Suppl 1):S105-7. PubMed ID: 9742502
    [No Abstract]   [Full Text] [Related]  

  • 13. Portal-systemic shunting in patients with fibrosis or cirrhosis due to chronic hepatitis C: the minimal model for measuring cholate clearances and shunt.
    Everson GT; Martucci MA; Shiffman ML; Sterling RK; Morgan TR; Hoefs JC;
    Aliment Pharmacol Ther; 2007 Aug; 26(3):401-10. PubMed ID: 17635375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Some pathogenetic aspects of developing liver failure and preventing it in patients with liver cirrhosis after portosystemic shunting].
    Nazyrov FG; Akilov KhA; Ibadov RA; Asabaev ASh; Zaĭnutdinov UI; Khafizov BB
    Vestn Khir Im I I Grek; 2002; 161(1):87-90. PubMed ID: 12048797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver transplantation in patients with a previous portasystemic shunt.
    Moreno-González E; Gomez R; Bonet H; Garcia I; Gonzalez-Pinto I; Loinaz C; Maffettone V
    Hepatogastroenterology; 1993 Dec; 40(6):593-5. PubMed ID: 8119646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new method for evaluation of portasystemic shunting. The rectal octanoate tolerance test.
    Linscheer WG; Castell DO; Platt RR
    Gastroenterology; 1969 Oct; 57(4):415-23. PubMed ID: 5212384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Endovascular intrahepatic portacaval shunting].
    Borisov AE; Ryzhkov VK; Karev AV; Kashchenko VA; Vasiukova EA
    Khirurgiia (Mosk); 2002; (6):34-7. PubMed ID: 12109183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Angiographic control of porto-systemic anastomoses].
    Troiani R; Lombardi M; Dell'Amico P; Pincione F; Fialdini G; Zappia F; Ambrogi M; Sicari A
    Minerva Chir; 1982 Jun; 37(12):1075-92. PubMed ID: 7121860
    [No Abstract]   [Full Text] [Related]  

  • 19. Effectiveness of Rex shunt in children with portal hypertension following liver transplantation or with primary portal hypertension.
    Krebs-Schmitt D; Briem-Richter A; Grabhorn E; Burdelski M; Helmke K; Broering DC; Ganschow R
    Pediatr Transplant; 2009 Aug; 13(5):540-4. PubMed ID: 19210267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Results of partial shunting in liver cirrhosis].
    Kalita NIa; Kotenko OG; Andreeshchev SA
    Klin Khir; 2000 Jun; (6):10-3. PubMed ID: 11288266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.